Lifeng-KY Reports May 2026 Revenue of NT$285.2 Million (YoY -14.6%)
AI Summary (NQ-processed)
Lifeng-KY (4137) announced revenue of NT$285.2 million (NT$285,203 thousand) for May 2026, representing a 14.6% year-on-year decline, highlighting a slowdown in performance within the biotech healthcare sector.
AI Analysis
Frequently Asked Questions
Q: What was Lifeng-KY's revenue in May 2026?
A: NT$285.203 million, down 14.6% year-on-year.
Q: What industry is Lifeng-KY in?
A: Biotech healthcare, focusing on pharmaceuticals, diagnostics, and medical devices.
Q: What does this performance mean for the market?
A: It signals a slowdown in the biotech sector, potentially increasing investor caution.